Utama › Sindrom Kesukaran Pernafasan › Tennessee
Kajian klinikal Sindrom Kesukaran Pernafasan di Tennessee
8 kajian untuk Sindrom Kesukaran Pernafasan sedang mencari peserta di lokasi di Tennessee.
Bandar di Tennessee
Teks kajian rasmi (Bahasa Inggeris)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06703073Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Knoxville
- Direct Biologics Investigational Site, Nashville
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 23 Feb 2026 · NCT05354141The APS Phenotyping Study
- Meharry Medical College, Nashville
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Feb 2026 · NCT06521502Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- The Jackson Clinic, PA, Jackson
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
- Western TN- Jackson-Madison County General Hospital, Jackson
Mengambil pesertaFasa 3
29 Weeks – 36 Weeks · Semua jantina · Dikemas kini 30 Mac 2025 · NCT05960929Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.